KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueDividends payablesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetLoans - NetMinority InterestOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Real Estate - Net (2016 - 2022)

National Health Investors filings provide 17 years of Revenue - Mortgage Backed Securities readings, the most recent being -$1.0 million for Q4 2025.

  • On a quarterly basis, Revenue - Mortgage Backed Securities changed N/A to -$1.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$600000.0, a 146.15% decrease, with the full-year FY2025 number at $200000.0, down 84.62% from a year prior.
  • Real Estate - Net hit $2.1 billion in Q4 2022 for National Health Investors, down from $2.3 billion in the prior quarter.
  • In the past five years, Real Estate - Net ranged from a high of $2.7 billion in Q4 2020 to a low of $2.1 billion in Q4 2022.
  • Median Real Estate - Net over the past 5 years was $2.4 billion (2018), compared with a mean of $2.4 billion.
  • Biggest five-year swings in Revenue - Mortgage Backed Securities: crashed 397.05% in 2021 and later skyrocketed 102.14% in 2022.
  • National Health Investors' Revenue - Mortgage Backed Securities stood at -$18.7 million in 2021, then soared by 102.14% to $400000.0 in 2022, then changed by 0.0% to $400000.0 in 2023, then fell by 25.0% to $300000.0 in 2024, then crashed by 433.33% to -$1.0 million in 2025.
  • The last three reported values for Revenue - Mortgage Backed Securities were -$1.0 million (Q4 2025), $100000.0 (Q3 2025), and $200000.0 (Q2 2025) per Business Quant data.